< Back to companies
Lembas

Lembas

Sheffield, United Kingdom

Lembas is an AI-powered bioactive discovery company pioneering the next generation of science-backed ingredients for functional foods and supplements. Our first solution GLP-1 Edge™, is a natural peptide that supports appetite regulation and metabolic health by enhancing the body’s own GLP-1 response. GLP-1 Edge™ is food-grade, clinically validated, and easy to integrate into everyday products like bars, shakes, snacks, gummies, and supplements. It works with the body, not against it, making it an ideal companion for consumers looking to manage their weight naturally, safely, and sustainably. At the core of Lembas is a proprietary AI platform that accelerates the discovery and design of targeted bioactive peptides. Backed by patent-pending university technology, Lembas is unlocking new bioactive ingredients across a broader range of health and wellbeing benefits. This is just the beginning. Stay tuned.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2024
Website
www.hellolembas.com/
Only accessible to MedStartr community members. Join now

What do you think of Lembas?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now